CRISPR THERAPEUTICS AG Property, Plant, and Equipment, Fair Value Disclosure
CRISPR THERAPEUTICS AG (CRSP) had Property, Plant, and Equipment, Fair Value Disclosure of $9.34 million as of 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:PropertyPlantAndEquipmentFairValueDisclosure · last filed 2022-02-15
- 2021-12-31: Property, Plant, and Equipment, Fair Value Disclosure $9.34M.
- 2021-09-30: Property, Plant, and Equipment, Fair Value Disclosure $9.34M.
- 2021-06-30: Property, Plant, and Equipment, Fair Value Disclosure $9.34M.
- 2021-03-31: Property, Plant, and Equipment, Fair Value Disclosure $9.34M.
| Period end | Property, Plant, and Equipment, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $9.34M 10-K · filed 2022-02-15 |
| 2021-09-30 | $9.34M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $9.34M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $9.34M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $9.34M 10-K · filed 2021-02-16 |
| 2020-09-30 | $9.34M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $9.34M 10-Q · filed 2020-07-27 |
| 2020-03-31 | $9.34M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $9.34M 10-K · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |